ESMO 2021 Post Hoc Analyses from PALOMA-2 and PALOMA-3: Effect of Palbociclib + Endocrine Therapy on Time to Chemotherapy Across Subgroups of Pts with HR+/HER2- Advanced Breast Cancer

November 10, 2021

0 Comments
Login to view comments. Click here to Login